APA

Nahi H., Remberger M., Machaczka M., Ungerstedt J., Mattson J., Ringden O., Le-Blanc K., Ljungman P. & Hägglund H. (20130726). Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution. : Medical oncology (Northwood, London, England).

Chicago

Nahi H, Remberger M, Machaczka M, Ungerstedt J, Mattson J, Ringden O, Le-Blanc Katarina, Ljungman P and Hägglund H. 20130726. Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution. : Medical oncology (Northwood, London, England).

Harvard

Nahi H., Remberger M., Machaczka M., Ungerstedt J., Mattson J., Ringden O., Le-Blanc K., Ljungman P. and Hägglund H. (20130726). Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution. : Medical oncology (Northwood, London, England).

MLA

Nahi H, Remberger M, Machaczka M, Ungerstedt J, Mattson J, Ringden O, Le-Blanc Katarina, Ljungman P and Hägglund H. Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution. : Medical oncology (Northwood, London, England). 20130726.